Previous 10 | Next 10 |
2023-05-04 10:38:25 ET Growth stocks have performed surprisingly well in 2023. Despite ever-rising interest rates, a possible recession, and a regional banking crisis, the growth-oriented Nasdaq Composite has ticked higher by an impressive 14.8% so far this year. Which growth st...
ZUG, Switzerland and CAMBRIDGE, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to partici...
2023-04-28 15:00:52 ET Summary Two months after my last bullish note on Crispr Therapeutics, predicting a bull run, the share price has barely budged. I find this surprising. Crispr and partner Vertex have now submitted their biologics license application to the FDA for approval o...
2023-04-27 08:15:00 ET CRISPR Therapeutics (NASDAQ: CRSP) has been a volatile stock over the past couple of years. Lately, the gene-editing company's shares have been trading for under $51 a share, but I believe they could go much higher, considering the company's long-term pote...
2023-04-26 10:07:00 ET CRISPR Therapeutics (NASDAQ: CRSP) is a growth stock with a lot of long-term potential. Its gene-editing business could be about to take off if exa-cel obtains approval from the Food and Drug Administration (FDA). And while that should drive plenty of bullishn...
2023-04-24 07:55:25 ET Bluebird bio ( NASDAQ: BLUE ) added ~5% pre-market Monday after the biotech announced the submission of its Biologics License Application (BLA) for lovo-cel seeking the FDA’s priority review as an ex-vivo gene therapy for sickle cell disease. ...
2023-04-22 06:18:00 ET In some industries, quarterly earnings updates provide the main news that holds the potential to drive stocks higher. It's a different story in the biopharmaceutical world. Clinical updates and regulatory decisions can happen throughout the year. Three Motley Fool...
2023-04-21 11:13:54 ET The following slide deck was published by CRISPR Therapeutics AG in conjunction with this event. For further details see: CRISPR Therapeutics (CRSP) Presents at AACR 2023 - Slideshow
2023-04-21 07:30:00 ET "If you aren't willing to own a stock for 10 years, don't even think about owning it for 10 minutes," billionaire investor Warren Buffett advised shareholders in his annual letter in 1996, reinforcing the need to focus on the long term. Two companies that could be...
2023-04-20 17:51:34 ET Gainers: ContextLogic ( WISH ) +28% . EyePoint Pharmaceuticals ( EYPT ) +7% . Caribou Biosciences ( CRBU ) +5% . Ocular Therapeutix ( OCUL ) +3% . Coherus BioSciences ( CHRS ) +3% . Losers: CRISPR T...
News, Short Squeeze, Breakout and More Instantly...
CRISPR Therapeutics AG Company Name:
CRSP Stock Symbol:
NASDAQ Market:
CRISPR Therapeutics AG Website: